Does TRICARE Cover Rehab?

TRICARE operates as military + retiree + dependent-focused, broadly generous cost-sharing, with 9.6 million (active duty, retirees, dependents) covered across all 50 states + overseas. Its parity compliance framework is enforced under MHPAEA; specific medical-necessity criteria must — under the 2024 Final Rule — be disclosed to plan participants upon request. The paragraphs that follow disaggregate the practical coverage framework.

Parity enforcement — what the 2024 rule changed

Under the 2024 MHPAEA Final Rule, TRICARE must prospectively document — via a written comparative analysis, using actual claims data — that non-quantitative treatment limits (prior authorization, medical-necessity criteria, network adequacy, step-therapy requirements) operate no more stringently for behavioral-health care than for medical-surgical care. On the empirical side, TRICARE has been among the insurers more responsive to documented medical-necessity cases post-2024, though variation by plan product remains meaningful. Disclosure of this analysis to plan participants, the Department of Labor, and (in litigation contexts) plaintiffs is now mandatory within 10 business days of request.

TRICARE plan types

TRICARE's products (TRICARE Prime, TRICARE Select, TRICARE for Life (Medicare-eligible), TRICARE Young Adult, TRICARE Overseas) carry variable benefit designs within a common regulatory framework. For addiction-treatment planning, the operative variables are: (1) deductible status at time of admission; (2) in-network versus out-of-network cost-share; (3) prior-authorization requirements; (4) medical-necessity criteria applied. All four should be documented in writing from TRICARE member services before admission.

A note on medication-assisted treatment

Federal guidance — SAMHSA TIP 63, NIDA Research Reports, ASAM Criteria 4e — designates MAT with buprenorphine, methadone, or naltrexone as first-line treatment for opioid use disorder. TRICARE's current MAT coverage: buprenorphine, methadone, naltrexone all covered; methadone requires federally-licensed opioid treatment program. Departures from consensus MAT standards in a plan's medical-necessity criteria are actionable under the 2024 parity rule's clinical-alignment requirement.

When TRICARE denies — appeal playbook

Under ERISA (for employer-sponsored TRICARE plans) and state insurance law (for individual/small-group TRICARE products), the appeal structure is: (1) internal review, 90-day window; (2) expedited internal review, 72-hour turnaround for urgent medical situations; (3) second-level review; (4) external review by IRO or state commissioner; (5) for ERISA plans, federal court under 29 U.S.C. § 1132(a)(1)(B). The 2024 MHPAEA Final Rule added a parity-specific enforcement pathway administered by the Department of Labor.

Before admission

Pre-admission benefit verification for TRICARE should produce written documentation of: deductible accumulated to date, coinsurance percentage applicable to in-network residential/PHP/IOP, out-of-pocket maximum accumulation, prior-authorization status and expected turnaround, formulary status for any requested MAT medication, and appeal rights disclosure. The operational bar is that the patient or family can produce any of the six documents if the claim is subsequently disputed.